Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 3/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
| ▸ | MME | P08473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10782261 | 0.92 | CYP2C19 (0.35) | EPHX1CYP2C19MME | |
| SCHEMBL15541915 | 0.80 | EPHX1 (0.39) | EPHX1L3MBTL1 | |
| SCHEMBL10793562 | 0.80 | EPHX1 (0.39) | EPHX1L3MBTL1 | |
| SCHEMBL15540956 | 0.80 | EPHX1 (0.39) | EPHX1L3MBTL1 | |
| SCHEMBL10405186 | 0.79 | GRM4 (0.36) | CYP2C19HSD11B1 | |
| SCHEMBL29052017 | 0.77 | CES2 (0.33) | EPHX1CYP2C19HSD11B1 | |
| SCHEMBL5183503 | 0.77 | EPHX1 (0.32) | EPHX1CYP2C19HSD11B1 | |
| SCHEMBL27548088 | 0.77 | EPHX1 (0.35) | EPHX1CYP2C19HSD11B1 | |
| SCHEMBL27880586 | 0.77 | GAA (0.33) | MME | |
| SCHEMBL15542322 | 0.76 | EPHX1 (0.34) | EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 205 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119425424-A | Polyamide composite membrane based on nanobubble-assisted free interface polymerization strategy and preparation method and application thereof | 中国海洋大学 | 2025-02-14 | — | — | CN | claimed |
| EP-2467374-A1 | NOVEL METHOD FOR PRODUCING 4-AMINOBUT-2-ENOLIDES | Bayer CropScience AG (DE) | 2012-06-27 | — | — | EP | claimed |
| EP-2443090-A1 | SUBSTITUTED ENAMINO CARBONYL COMPOUNDS | Bayer Cropscience AG (DE) | 2012-04-25 | — | — | EP | claimed |
| EP-2408764-A1 | NOVEL METHOD FOR PRODUCING ENAMINOCARBONYL COMPOUNDS | Bayer Cropscience AG (DE) | 2012-01-25 | — | — | EP | claimed |
| EP-2408765-A1 | NOVEL METHOD FOR PRODUCING ENAMINOCARBONYL COMPOUNDS | Bayer CropScience AG (DE) | 2012-01-25 | — | — | EP | claimed |
| WO-2011020564-A1 | NOVEL METHOD FOR PRODUCING 4-AMINOBUT-2-ENOLIDES | BAYER CROPSCIENCE AG (DE) | 2011-02-24 | — | — | WO | claimed |
| WO-2010145764-A1 | SUBSTITUTED ENAMINO CARBONYL COMPOUNDS | BAYER CROPSCIENCE AG (DE) | 2010-12-23 | — | — | WO | claimed |
| WO-2010105779-A1 | NOVEL METHOD FOR PRODUCING ENAMINOCARBONYL COMPOUNDS | BAYER CROPSCIENCE AG (DE) | 2010-09-23 | — | — | WO | claimed |
| WO-2010105772-A1 | NOVEL METHOD FOR PRODUCING ENAMINOCARBONYL COMPOUNDS | BAYER CROPSCIENCE AG (DE) | 2010-09-23 | — | — | WO | claimed |
| EP-1405625-B1 | Cosmetic composition comprising oils, a rheological agent and a particulate phase | OREAL (FR) | 2010-03-24 | — | — | EP | claimed |
| CN-1658819-A | Care and/or make-up cosmetic composition structured with silicone polymers and organogelling agents, in rigid form | OREAL (FR) | 2005-08-24 | — | — | CN | claimed |
| EP-1515684-A2 | CARE AND/OR MAKE-UP COSMETIC COMPOSITION STRUCTURED WITH SILICONE POLYMERS AND ORGANOGELLING AGENTS, IN RIGID FORM | L'OREAL (FR) | 2005-03-23 | — | — | EP | claimed |
| US-20040223987-A1 | Composition structured with a polymer containing a heteroatom and organogelator | L'OREAL S.A. (FR) | 2004-11-11 | — | — | US | claimed |
| EP-1405625-A1 | Cosmetic composition comprising oils, a rheological agent and a pariculate phase | L'OREAL (FR) | 2004-04-07 | — | — | EP | claimed |
| WO-2003105788-A2 | CARE AND/OR MAKE-UP COSMETIC COMPOSITION STRUCTURED WITH SILICONE POLYMERS AND ORGANOGELLING AGENTS, IN RIGID FORM | L'OREAL (FR) | 2003-12-24 | — | — | WO | claimed |
| US-20030091520-A1 | Use of at least one polar additive in a cosmetic composition comprising a liquid fatty phase structured by at least one molecular organogelator, to impart a thixotropic character to the composition | L'OREAL (FR) | 2003-05-15 | — | — | US | claimed |
| EP-1294342-A2 | COMPOSITION STRUCTURED WITH A POLYMER CONTAINING AHETEROATOM AND AN ORGANOGELATOR | L'OREAL (FR) | 2003-03-26 | — | — | EP | claimed |
| EP-1264589-A1 | Use of a polar additive in a cosmetic composition containing a structured liquid oil phase by at least one organogelator to give a thixotropic character | L'OREAL (FR) | 2002-12-11 | — | — | EP | claimed |
| WO-2002055030-A2 | COMPOSITION STRUCTURED WITH A POLYMER CONTAINING A HETEROATOM AND ORGANOGELATOR | OREAL (FR) | 2002-07-18 | — | — | WO | claimed |
| WO-2002047628-A1 | COMPOSITION STRUCTURED WITH A POLYMER CONTAINING A HETEROATOM AND AN ORGANOGELATOR | L'ORÉAL (FR) | 2002-06-20 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040223987-A1 | Composition structured with a polymer containing a heteroatom and organogelator | CUTA, PARG, FABP4 | EPHX1 1368/4885L3MBTL1 1721/4885CYP2C19 556/4885 |
| US-20030091520-A1 | Use of at least one polar additive in a cosmetic composition comprising a liquid fatty phase structured by at least one molecular organogelator, to impart a thixotropic character to the composition | PLIN3, CUTA, FABP4 | EPHX1 542/4885L3MBTL1 3077/4885CYP2C19 1866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.